S100A9 and myelodysplastic syndrome: We previously demonstrated that S100a9 is highly expressed in lower-risk Myelodysplastic Syndromes-bone marrow-mononuclear cells (MDS-BM-MNCs) and expressed at low levels in higher-risk MDS-BM-MNCs[4].